Imatinib mesylate (Gleevec) induced remission in Philadelphia chromosome-negative BCR-ABL negative atypical chronic myelogenous leukemia (CML).

被引：0
|
作者：
Seftel, MD
Horsman, DE
Berry, B
Parslow, M
Pewarchuk, WJ
Nantel, SH
机构：
[1] Vancouver Gen Hosp, Leukemia BMT Program British Columbia, Vancouver, BC, Canada
[2] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
[3] Capital Hlth Reg, Dept Pathol, Victoria, BC, Canada
[4] Cowichan Community Canc Ctr, Cowichan, BC, Canada
[5] Univ British Columbia, Dept Med, Vancouver, BC V5Z 1M9, Canada
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4856
引用
收藏
页码：326B / 327B
页数：2
相关论文
共 50 条
  • [41] COEXPRESSION OF C-ABL AND C-MYB ONCOGENES IN PHILADELPHIA CHROMOSOME-NEGATIVE, BCR-NEGATIVE CHRONIC MYELOID-LEUKEMIA
    TOTH, FD
    KISS, J
    KISS, A
    TELEK, B
    OLAH, E
    IVANYI, J
    RAK, K
    LEUKEMIA RESEARCH, 1994, 18 (05) : 373 - 380
  • [42] Quantitative polymerase chain reaction monitoring of BCR-ABL during therapy with imatinib mesylate (STI571; gleevec) in chronic-phase chronic myelogenous leukemia
    Kantarjian, HM
    Talpaz, M
    Cortes, J
    O'Brien, S
    Faderl, S
    Thomas, D
    Giles, F
    Rios, MB
    Shan, JQ
    Arlinghaus, R
    CLINICAL CANCER RESEARCH, 2003, 9 (01) : 160 - 166
  • [43] Imatinib mesylate-induced long-standing acute hepatitis in a patient with BCR/ABL plus chronic myelogenous leukemia (CML).
    Symeonidis, AS
    Kouraklis-Symeonidis, AH
    Lambropoulou-Karatza, C
    Tsamantas, A
    Thomopoulos, C
    Zoumbos, N
    BLOOD, 2003, 102 (11) : 318B - 318B
  • [44] Prognostic significance of the type of BCR-ABL transcript in chronic myelogenous leukemia (CML)
    Mantzourani, M
    Viniou, N
    Stavroyianni, N
    Rombos, J
    Meletis, J
    Loukopoulos, D
    Yataganas, X
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 275 - 275
  • [45] Philadelphia-negative acute lymphoblastic leukemia developing in a CML patient in imatinib mesylate-induced complete cytogenetic remission
    S Cherrier-De Wilde
    K Rack
    P Vannuffel
    A Delannoy
    A Hagemeijer
    Leukemia, 2003, 17 : 2046 - 2048
  • [46] POLYMERASE CHAIN-REACTION ANALYSIS OF BCR-ABL SEQUENCES IN ADULT PHILADELPHIA CHROMOSOME-NEGATIVE ACUTE LYMPHOBLASTIC-LEUKEMIA PATIENTS
    JANSSEN, JWG
    FONATSCH, C
    LUDWIG, WD
    RIEDER, H
    MAURER, J
    BARTRAM, CR
    LEUKEMIA, 1992, 6 (05) : 463 - 464
  • [47] PROGNOSTIC DETERMINANTS IN PATIENTS (PTS) WITH PHILADELPHIA CHROMOSOME-NEGATIVE (PH-VE) BENIGN PHASE CHRONIC MYELOGENOUS LEUKEMIA (CML)
    KANTARJIAN, H
    KEATING, M
    MCCREDIE, K
    WALTERS, R
    TALPAZ, M
    BERAN, M
    SMITH, T
    FREIREICH, E
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 151 - 151
  • [48] Philadelphia-negative acute lymphoblastic leukemia developing in a CML patient in imatinib mesylate-induced complete cytogenetic remission
    Cherrier-De Wilde, S
    Rack, K
    Vannuffel, P
    Delannoy, A
    Hagemeijer, A
    LEUKEMIA, 2003, 17 (10) : 2046 - 2048
  • [49] Isolated Clonal Trisomy 13 in Philadelphia Chromosome-Negative Metaphases in Patients with Chronic Myelogenous Leukemia
    Yin, C. C.
    Hu, S.
    Medeiros, L. J.
    Lu, G.
    MODERN PATHOLOGY, 2012, 25 : 383A - 383A
  • [50] Isolated Clonal Trisomy 13 in Philadelphia Chromosome-Negative Metaphases in Patients with Chronic Myelogenous Leukemia
    Yin, C. C.
    Hu, S.
    Medeiros, L. J.
    Lu, G.
    LABORATORY INVESTIGATION, 2012, 92 : 383A - 383A
12345